GPT and cancer: This telomerase-independent pathway enables the maintenance of telomere length through homologous recombination, highlighting the need for therapeutic strategies that can target both telomerase-dependent and ALT-dependent cancers, as these mechanisms contribute to resistance against telomerase-targeted therapies [122].